2023 Q2 Form 10-Q Financial Statement

#000104631123000021 Filed on May 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $427.4M $332.8M
YoY Change 16.15% 29.13%
Cost Of Revenue $207.3M $168.5M
YoY Change 34.72% 48.25%
Gross Profit $220.2M $164.3M
YoY Change 2.81% 14.04%
Gross Profit Margin 51.51% 49.37%
Selling, General & Admin $67.80M $59.28M
YoY Change 54.49% 95.5%
% of Gross Profit 30.8% 36.08%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $9.812M $10.02M
YoY Change 79.08% 60.86%
% of Gross Profit 4.46% 6.1%
Operating Expenses $67.80M $59.28M
YoY Change 54.49% 95.5%
Operating Profit $124.4M $77.85M
YoY Change -20.95% -21.68%
Interest Expense $16.27M $14.08M
YoY Change 44.6% 22.79%
% of Operating Profit 13.08% 18.09%
Other Income/Expense, Net -$11.84M -$10.36M
YoY Change -22.21% -11.2%
Pretax Income $112.5M $67.50M
YoY Change -20.81% -23.07%
Income Tax $27.84M $14.68M
% Of Pretax Income 24.73% 21.74%
Net Earnings $84.71M $52.82M
YoY Change -20.21% -21.62%
Net Earnings / Revenue 19.82% 15.87%
Basic Earnings Per Share $1.66 $1.02
Diluted Earnings Per Share $1.65 $1.02
COMMON SHARES
Basic Shares Outstanding 50.99M shares 51.45M shares
Diluted Shares Outstanding 50.99M shares 51.71M shares

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $36.17M $31.68M
YoY Change -94.04% -93.99%
Cash & Equivalents $36.17M $31.68M
Short-Term Investments
Other Short-Term Assets $33.82M $37.48M
YoY Change -70.76% 39.83%
Inventory
Prepaid Expenses
Receivables $220.1M $214.1M
Other Receivables $58.05M $57.83M
Total Short-Term Assets $348.1M $341.1M
YoY Change -64.61% -56.72%
LONG-TERM ASSETS
Property, Plant & Equipment $449.3M $434.3M
YoY Change 40.78% 9.96%
Goodwill $220.2M $220.2M
YoY Change 38.31% 38.31%
Intangibles $764.4M $750.2M
YoY Change 138.93% 141.15%
Long-Term Investments $81.22M $67.97M
YoY Change 40.99% 9.11%
Other Assets $87.16M $89.14M
YoY Change 2.57% 4.66%
Total Long-Term Assets $1.802B $1.765B
YoY Change 64.85% 49.08%
TOTAL ASSETS
Total Short-Term Assets $348.1M $341.1M
Total Long-Term Assets $1.802B $1.765B
Total Assets $2.150B $2.106B
YoY Change 3.54% 6.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $121.0M $93.14M
YoY Change 13.67% 3.68%
Accrued Expenses $98.79M $78.84M
YoY Change -1.83% -2.98%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $4.416M $4.416M
YoY Change -97.96% -97.96%
Total Short-Term Liabilities $406.7M $369.6M
YoY Change -30.16% -34.42%
LONG-TERM LIABILITIES
Long-Term Debt $1.384B $1.375B
YoY Change 63.87% 62.81%
Other Long-Term Liabilities $7.795M $8.277M
YoY Change 5.95% 20.92%
Total Long-Term Liabilities $1.392B $1.383B
YoY Change 63.37% 62.47%
TOTAL LIABILITIES
Total Short-Term Liabilities $406.7M $369.6M
Total Long-Term Liabilities $1.392B $1.383B
Total Liabilities $2.096B $2.059B
YoY Change 26.23% 24.24%
SHAREHOLDERS EQUITY
Retained Earnings $1.664B $1.594B
YoY Change 16.99% 19.89%
Common Stock $311.3M $300.0M
YoY Change 13.45% 13.03%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $54.69M $47.01M
YoY Change
Total Liabilities & Shareholders Equity $2.150B $2.106B
YoY Change 3.54% 6.8%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income $84.71M $52.82M
YoY Change -20.21% -21.62%
Depreciation, Depletion And Amortization $9.812M $10.02M
YoY Change 79.08% 60.86%
Cash From Operating Activities $113.7M $12.03M
YoY Change 19.16% -81.18%
INVESTING ACTIVITIES
Capital Expenditures $26.41M $20.66M
YoY Change -207.65% -173.75%
Acquisitions
YoY Change
Other Investing Activities -$3.281M $771.0K
YoY Change -114.26% 45.75%
Cash From Investing Activities -$29.69M -$29.46M
YoY Change 1847.97% 31.14%
FINANCING ACTIVITIES
Cash Dividend Paid $12.82M
YoY Change -2.9%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -79.57M $7.440M
YoY Change 491.01% -128.84%
NET CHANGE
Cash From Operating Activities 113.7M $12.03M
Cash From Investing Activities -29.69M -$29.46M
Cash From Financing Activities -79.57M $7.440M
Net Change In Cash 4.451M -$9.990M
YoY Change -94.47% -163.78%
FREE CASH FLOW
Cash From Operating Activities $113.7M $12.03M
Capital Expenditures $26.41M $20.66M
Free Cash Flow $87.30M -$8.630M
YoY Change -27.22% -109.39%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
CHOICE HOTELS INTERNATIONAL INC /DE
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001046311
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-13393
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
52-1209792
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
1 Choice Hotels Circle
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
20850
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
592-5000
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, Par Value $0.01 per share
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Rockville,
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
MD
CY2023Q1 dei City Area Code
CityAreaCode
301
CY2023Q1 dei Trading Symbol
TradingSymbol
CHH
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
50991519 shares
CY2023Q1 us-gaap Revenues
Revenues
332792000 usd
CY2022Q1 us-gaap Revenues
Revenues
257727000 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
59283000 usd
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
30324000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10023000 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6231000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
254941000 usd
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
158359000 usd
CY2023Q1 chh Gain Loss On Disposition Of Business And Assets
GainLossOnDispositionOfBusinessAndAssets
0 usd
CY2022Q1 chh Gain Loss On Disposition Of Business And Assets
GainLossOnDispositionOfBusinessAndAssets
29000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
77851000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
99397000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
14084000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
11470000 usd
CY2023Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
1883000 usd
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
1280000 usd
CY2023Q1 us-gaap Other Nonoperating Gains Losses
OtherNonoperatingGainsLosses
1908000 usd
CY2022Q1 us-gaap Other Nonoperating Gains Losses
OtherNonoperatingGainsLosses
-1716000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-63000 usd
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
244000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-10356000 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-11662000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
67495000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
87735000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
53214000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14675000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
20344000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
52820000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
67391000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.02
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.21
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.02
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.20
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.2875
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.2375
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
52820000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
67391000 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
394000 usd
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-134000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
394000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-134000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
67257000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
31679000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
41566000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
24558000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
23435000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
214103000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
216614000 usd
CY2023Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
4736000 usd
CY2022Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
4759000 usd
CY2023Q1 us-gaap Allowance For Notes And Loans Receivable Current
AllowanceForNotesAndLoansReceivableCurrent
3988000 usd
CY2022Q4 us-gaap Allowance For Notes And Loans Receivable Current
AllowanceForNotesAndLoansReceivableCurrent
4125000 usd
CY2023Q1 us-gaap Notes And Loans Receivable Gross Current
NotesAndLoansReceivableGrossCurrent
53093000 usd
CY2022Q4 us-gaap Notes And Loans Receivable Gross Current
NotesAndLoansReceivableGrossCurrent
52466000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
37477000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
32517000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
341088000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
347922000 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
266825000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
253323000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
434282000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
427306000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
66398000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
68985000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
220187000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
218653000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
205769000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
201401000 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
750179000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
742190000 usd
CY2023Q1 us-gaap Allowance For Notes And Loans Receivable Noncurrent
AllowanceForNotesAndLoansReceivableNoncurrent
6370000 usd
CY2022Q4 us-gaap Allowance For Notes And Loans Receivable Noncurrent
AllowanceForNotesAndLoansReceivableNoncurrent
6047000 usd
CY2023Q1 us-gaap Notes And Loans Receivable Gross Noncurrent
NotesAndLoansReceivableGrossNoncurrent
56382000 usd
CY2022Q4 us-gaap Notes And Loans Receivable Gross Noncurrent
NotesAndLoansReceivableGrossNoncurrent
55577000 usd
CY2023Q1 chh Deferred Compensation Arrangement Assetsfor Plan Benefits Noncurrent
DeferredCompensationArrangementAssetsforPlanBenefitsNoncurrent
34758000 usd
CY2022Q4 chh Deferred Compensation Arrangement Assetsfor Plan Benefits Noncurrent
DeferredCompensationArrangementAssetsforPlanBenefitsNoncurrent
31645000 usd
CY2023Q1 us-gaap Real Estate Investments Unconsolidated Real Estate And Other Joint Ventures
RealEstateInvestmentsUnconsolidatedRealEstateAndOtherJointVentures
33216000 usd
CY2022Q4 us-gaap Real Estate Investments Unconsolidated Real Estate And Other Joint Ventures
RealEstateInvestmentsUnconsolidatedRealEstateAndOtherJointVentures
30647000 usd
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
80593000 usd
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
88182000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
89140000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
91068000 usd
CY2023Q1 us-gaap Assets
Assets
2106223000 usd
CY2022Q4 us-gaap Assets
Assets
2102175000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
93135000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
118863000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
78842000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
131410000 usd
CY2023Q1 chh Contract With Customers Liability And Non606 Deferred Revenue Current
ContractWithCustomersLiabilityAndNon606DeferredRevenueCurrent
103599000 usd
CY2022Q4 chh Contract With Customers Liability And Non606 Deferred Revenue Current
ContractWithCustomersLiabilityAndNon606DeferredRevenueCurrent
92695000 usd
CY2023Q1 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
4416000 usd
CY2022Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
2976000 usd
CY2023Q1 us-gaap Deferred Income Current
DeferredIncomeCurrent
89582000 usd
CY2022Q4 us-gaap Deferred Income Current
DeferredIncomeCurrent
89954000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
369574000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
435898000 usd
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1374814000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1200547000 usd
CY2023Q1 chh Contract With Customers Liability And Non606 Deferred Revenue Noncurrent
ContractWithCustomersLiabilityAndNon606DeferredRevenueNoncurrent
132520000 usd
CY2022Q4 chh Contract With Customers Liability And Non606 Deferred Revenue Noncurrent
ContractWithCustomersLiabilityAndNon606DeferredRevenueNoncurrent
134149000 usd
CY2023Q1 chh Deferred Compensation And Retirement Plan Obligations Noncurrent
DeferredCompensationAndRetirementPlanObligationsNoncurrent
40420000 usd
CY2022Q4 chh Deferred Compensation And Retirement Plan Obligations Noncurrent
DeferredCompensationAndRetirementPlanObligationsNoncurrent
36673000 usd
CY2023Q1 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
15482000 usd
CY2022Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
15482000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
69708000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
70994000 usd
CY2023Q1 us-gaap Deferred Income Noncurrent
DeferredIncomeNoncurrent
48420000 usd
CY2022Q4 us-gaap Deferred Income Noncurrent
DeferredIncomeNoncurrent
47381000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8277000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6391000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
2059215000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1947515000 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
160000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
160000000 shares
CY2022 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
-938000 usd
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
95065638 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
95065638 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
51174432 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
52200903 shares
CY2023Q1 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
951000 usd
CY2022Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
951000 usd
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
299952000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
298053000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4817000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-5211000 usd
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
43891206 shares
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
42864735 shares
CY2023Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
1842913000 usd
CY2022Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
1694857000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1593835000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1555724000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
47008000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
154660000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2106223000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2102175000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
52820000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
67391000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10023000 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6231000 usd
CY2023Q1 chh Depreciation Depletion And Amortization Marketing And Reservation System
DepreciationDepletionAndAmortizationMarketingAndReservationSystem
9276000 usd
CY2022Q1 chh Depreciation Depletion And Amortization Marketing And Reservation System
DepreciationDepletionAndAmortizationMarketingAndReservationSystem
7154000 usd
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 usd
CY2022Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
29000 usd
CY2023Q1 chh Amortization Franchise Agreement Acquisition Cost
AmortizationFranchiseAgreementAcquisitionCost
4637000 usd
CY2022Q1 chh Amortization Franchise Agreement Acquisition Cost
AmortizationFranchiseAgreementAcquisitionCost
3784000 usd
CY2023Q1 chh Non Cash Stock Compensation And Other Charges
NonCashStockCompensationAndOtherCharges
10630000 usd
CY2022Q1 chh Non Cash Stock Compensation And Other Charges
NonCashStockCompensationAndOtherCharges
7555000 usd
CY2023Q1 chh Noncash Interest And Investment Income
NoncashInterestAndInvestmentIncome
-1442000 usd
CY2022Q1 chh Noncash Interest And Investment Income
NoncashInterestAndInvestmentIncome
1909000 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-7566000 usd
CY2022Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
3119000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
-421000 usd
CY2022Q1 us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
-230000 usd
CY2023Q1 chh Franchise Agreement Acquisition Cost Net Of Reimbursements
FranchiseAgreementAcquisitionCostNetOfReimbursements
-28092000 usd
CY2022Q1 chh Franchise Agreement Acquisition Cost Net Of Reimbursements
FranchiseAgreementAcquisitionCostNetOfReimbursements
-12435000 usd
CY2023Q1 chh Change In Working Capital And Other Net Of Acquisition
ChangeInWorkingCapitalAndOtherNetOfAcquisition
-53806000 usd
CY2022Q1 chh Change In Working Capital And Other Net Of Acquisition
ChangeInWorkingCapitalAndOtherNetOfAcquisition
-14747000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
12033000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
63924000 usd
CY2023Q1 us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
19566000 usd
CY2022Q1 us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
26809000 usd
CY2023Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1097000 usd
CY2022Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1208000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
CY2022Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
8494000 usd
CY2023Q1 us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
3620000 usd
CY2022Q1 us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
268000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
868000 usd
CY2022Q1 us-gaap Proceeds From Sale Of Equity Method Investments
ProceedsFromSaleOfEquityMethodInvestments
0 usd
CY2023Q1 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
2670000 usd
CY2022Q1 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
2818000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
716000 usd
CY2022Q1 us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
1853000 usd
CY2023Q1 us-gaap Origination Of Notes Receivable From Related Parties
OriginationOfNotesReceivableFromRelatedParties
3660000 usd
CY2022Q1 us-gaap Origination Of Notes Receivable From Related Parties
OriginationOfNotesReceivableFromRelatedParties
1245000 usd
CY2023Q1 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
337000 usd
CY2022Q1 us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
63000 usd
CY2023Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
771000 usd
CY2022Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
529000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-29463000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-22467000 usd
CY2023Q1 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
176000000 usd
CY2022Q1 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
0 usd
CY2023Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
755000 usd
CY2022Q1 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
160488000 usd
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
14802000 usd
CY2023Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
12821000 usd
CY2022Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
13204000 usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5504000 usd
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2211000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7440000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-25795000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-9990000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
15662000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
103000 usd
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-58000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
41566000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
511605000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31679000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
527209000 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1603000 usd
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
513000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
13396000 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
14462000 usd
CY2023Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
14985000 usd
CY2022Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
13250000 usd
CY2023Q1 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
6704000 usd
CY2022Q1 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
4129000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
265882000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
67391000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-134000 usd
CY2022Q1 chh Share Based Payment Activity
ShareBasedPaymentActivity
9558000 usd
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.2375
CY2022Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
13250000 usd
CY2022Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
14802000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
314645000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
154660000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
52820000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
394000 usd
CY2023Q1 chh Share Based Payment Activity
ShareBasedPaymentActivity
15396000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.2875
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
14709000 usd
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
161553000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
47008000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
209359000 usd
CY2023Q1 chh Contractwith Customer Liability Cash Received
ContractwithCustomerLiabilityCashReceived
24053000 usd
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
27549000 usd
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
205863000 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
205900000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
332793000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
257727000 usd
CY2023Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
119833000 usd
CY2022Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
118215000 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
10358000 usd
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
10172000 usd
CY2023Q1 us-gaap Notes Receivable Net
NotesReceivableNet
109475000 usd
CY2022Q4 us-gaap Notes Receivable Net
NotesReceivableNet
108043000 usd
CY2023Q1 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
53093000 usd
CY2022Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
52466000 usd
CY2023Q1 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
56382000 usd
CY2022Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
55577000 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
156000 usd
CY2023Q1 us-gaap Financing Receivable Originated In Current Fiscal Year
FinancingReceivableOriginatedInCurrentFiscalYear
3480000 usd
CY2023Q1 us-gaap Financing Receivable Originated In Fiscal Year Before Latest Fiscal Year
FinancingReceivableOriginatedInFiscalYearBeforeLatestFiscalYear
390000 usd
CY2023Q1 us-gaap Financing Receivable Originated Two Years Before Latest Fiscal Year
FinancingReceivableOriginatedTwoYearsBeforeLatestFiscalYear
9306000 usd
CY2023Q1 us-gaap Financing Receivable Originated Three Years Before Latest Fiscal Year
FinancingReceivableOriginatedThreeYearsBeforeLatestFiscalYear
953000 usd
CY2023Q1 us-gaap Financing Receivable Originated Four Years Before Latest Fiscal Year
FinancingReceivableOriginatedFourYearsBeforeLatestFiscalYear
29022000 usd
CY2023Q1 us-gaap Financing Receivable Originated Five Or More Years Before Latest Fiscal Year
FinancingReceivableOriginatedFiveOrMoreYearsBeforeLatestFiscalYear
76682000 usd
CY2023Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
119833000 usd
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
10172000 usd
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
16779000 usd
CY2023Q1 us-gaap Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
342000 usd
CY2022 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
5669000 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
10358000 usd
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
10172000 usd
CY2022 chh Number Of Loans With Revised Provisions
NumberOfLoansWithRevisedProvisions
2 loan
CY2023Q1 us-gaap Notes Receivable Gross
NotesReceivableGross
119833000 usd
CY2022Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
118215000 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Loss Writeoff After Recovery
FinancingReceivableAllowanceForCreditLossWriteoffAfterRecovery
2800000 usd
CY2022Q1 us-gaap Financing Receivable Allowance For Credit Loss Writeoff After Recovery
FinancingReceivableAllowanceForCreditLossWriteoffAfterRecovery
300000 usd
CY2022Q1 us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
0 usd
CY2023Q1 us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
0 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
1379230000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
1203523000 usd
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
4416000 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
2976000 usd
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1374814000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1200547000 usd
CY2023Q1 us-gaap Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
394000 usd
CY2022Q1 us-gaap Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
-134000 usd
CY2023Q1 chh Number Of Brands
NumberOfBrands
22 brand
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.217
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.232
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9771000 usd
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7449000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
52820000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
67391000 usd
CY2023Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
272000 usd
CY2022Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
324000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
52548000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
67067000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51269000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55412000 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.02
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.21
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
52820000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
67391000 usd
CY2023Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
272000 usd
CY2022Q1 us-gaap Participating Securities Distributed And Undistributed Earnings Loss Diluted
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
324000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
52548000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
67067000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51269000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55412000 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
445000 shares
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
642000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51714000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56054000 shares
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.02
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.20
CY2023Q1 chh Number Of Brands
NumberOfBrands
22 brand
CY2023Q1 chh Number Of Hotel Management Operations
NumberOfHotelManagementOperations
13 hotel
CY2023Q1 chh Number Of Owned Hotels
NumberOfOwnedHotels
3 hotel
CY2023Q1 us-gaap Revenues
Revenues
332792000 usd
CY2022Q1 us-gaap Revenues
Revenues
257727000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
77851000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
99397000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
67495000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
87735000 usd
CY2023Q1 chh Limited Payment Guaranties
LimitedPaymentGuaranties
5700000 usd
CY2023Q1 us-gaap Other Commitment
OtherCommitment
700000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
220187000 usd

Files In Submission

Name View Source Status
chh-20230331_pre.xml Edgar Link unprocessable
chh-20230331_cal.xml Edgar Link unprocessable
0001046311-23-000021-index-headers.html Edgar Link pending
0001046311-23-000021-index.html Edgar Link pending
0001046311-23-000021.txt Edgar Link pending
0001046311-23-000021-xbrl.zip Edgar Link pending
chh-20230331.htm Edgar Link pending
chh-20230331.xsd Edgar Link pending
chh-ex311x33123pacious.htm Edgar Link pending
chh-ex312x33123dragisich.htm Edgar Link pending
chh-ex32x33123dragisichand.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
chh-20230331_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
chh-20230331_lab.xml Edgar Link unprocessable
chh-20230331_htm.xml Edgar Link completed
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending